TopiVert Overview
- Year Founded
-
2010
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Out of Business
TopiVert General Information
Description
Developer of medical inhibition technologies designed to treat chronic inflammatory diseases of the gastrointestinal tract and the eyes. The company's technologies are used for the treatment of ulcerative colitis to deliver strong data with an oral formulation and medication consistently to the colon at pharmacologically relevant concentrations, enabling physicians to begin treatment more quickly, resulting in a better medical outcome.
Contact Information
Website
www.topivert.comCorporate Office
- 71 Kingsway
- London WC2B 6ST
- England, United Kingdom
Corporate Office
- 71 Kingsway
- London WC2B 6ST
- England, United Kingdom
TopiVert Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | 18-Jan-2021 | Completed | Out of Business | |||
| 5. Later Stage VC | 01-Jun-2018 | Completed | Clinical Trials - Phase 1 | |||
| 4. Later Stage VC (Series A2) | 15-Apr-2016 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC (Series A2) | 29-Sep-2014 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC (Series A2) | 31-Aug-2012 | $12.6M | $12.6M | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | Completed | Startup |
TopiVert Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 |
TopiVert Comparisons
Industry
Financing
Details
TopiVert Competitors (36)
One of TopiVert’s 36 competitors is CSL Behring (Biotechnology), a Corporation company based in Vienna, Austria.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CSL Behring (Biotechnology) | Corporation | Vienna, Austria | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Renova Therapeutics | Venture Capital-Backed | Carlsbad, CA | ||||
| CSL Behring | Corporation | King Of Prussia, PA | ||||
| Lexeo Therapeutics | Formerly VC-backed | New York, NY |
TopiVert Patents
TopiVert Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3015978-A1 | Kinase inhibitors | Inactive | 06-Apr-2016 | ||
| WO-2017174995-A1 | Kinase inhibitors | Inactive | 06-Apr-2016 | ||
| ES-2840650-T3 | 4,5,6,7-tetrahydro-1h-imidazo [4,5-c] pyridine and 1,4,5,6,7,8-hexahydroimidazo [4,5-d] azepine derivatives as kinase inhibitors janus | Active | 03-Nov-2015 | ||
| ES-2864035-T3 | 4,5,6,7-tetrahydro-1h-imidazo [4,5-c] pyridine and 1,4,5,6,7,8-hexahydroimidazo [4,5-d] azepine derivatives as kinase inhibitors janus | Active | 03-Nov-2015 | ||
| CA-3037248-A1 | 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as janus kinase inhibitors | Inactive | 03-Nov-2015 | C07D471/04 |
TopiVert Signals
TopiVert FAQs
-
When was TopiVert founded?
TopiVert was founded in 2010.
-
Where is TopiVert headquartered?
TopiVert is headquartered in London, United Kingdom.
-
What is the size of TopiVert?
TopiVert has 11 total employees.
-
What industry is TopiVert in?
TopiVert’s primary industry is Biotechnology.
-
Is TopiVert a private or public company?
TopiVert is a Private company.
-
What is TopiVert’s current revenue?
The current revenue for TopiVert is .
-
How much funding has TopiVert raised over time?
TopiVert has raised $37.7M.
-
Who are TopiVert’s competitors?
CSL Behring (Biotechnology), Genentech, Renova Therapeutics, CSL Behring, and Lexeo Therapeutics are some of the 36 competitors of TopiVert.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process